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Correction to: British Journal of Cancer (2006) 95, 363–365.
doi:10.1038/sj.bjc.6603250
Owing to an author error, there was a mistake in the presentation
of results in Table 1 in the above paper. All figures in the table were
correct, but the number of cases, person-years and rate ratios
presented for NSAID users with 2–9 prescriptions were
those pertaining to NSAID users with 10þ prescriptions, and
vice versa. Correction of this interchange of results has no
implications for the presentation of results in the article text, and
conclusions and abstract remain the same. The correct Table 1 is
shown below.
Table 1 Age- and gender-standardized rate ratios for oral cancer among
NSAID users in North Jutland County, Denmark, 1991–2002
No. of
cases Person-years
Standardised rate
ratio (95% CI)
All
No prescriptions 110 2521145 Reference
2+ prescriptions 75 977627 1.2 (1.0–1.6)
2–9 prescriptions 58 785386 1.3 (1.0–1.6)
10+ prescriptions 17 192241 1.0 (0.6–1.6)
No chronic obstructive pulmonary disease
a
No prescriptions 102 2436925 Reference
2+ prescriptions 66 919129 1.2 (0.9–1.5)
2–9 prescriptions 53 744208 1.3 (1.0–1.7)
10+ prescriptions 13 174921 0.9 (0.5–1.6)
Chronic obstructive pulmonary disease
No prescriptions 8 84220 Reference
2+ prescriptions 9 58499 0.9 (0.4–1.7)
2–9 prescriptions 5 41179 0.8 (0.2–1.8)
10+ prescriptions 4 17320 1.2 (0.3–3.1)
aNo hospitalisation for chronic obstructive pulmonary disease.
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